ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.65
0.17%
US Tech 100
20,882.00
0.05%
S&P 500
6,039.31
-0.47%
US Dollar vs CAD
1.44305
0.21%
Bitcoin
104,958.18
1.18%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSXV

  6. Acasti Pharma Inc (ACST) Share Price

Acasti Pharma Inc

Acasti Pharma Inc (ACST)

Acasti Pharma Inc
0.58
0.00
(0.00%)
Closed January 30 3:00PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
0.58
Bid
0.58
Ask
0.98
Volume
-
0.00 Day's Range 0.00
0.58 52 Week Range 0.58
Market Cap
5.451M
Previous Close
0.58
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
9,399,000
Dividend Yield
-
PE Ratio
-2.46
Earnings Per Share (EPS)
-1.37
Revenue
-
Net Profit
-12.85M

About Acasti Pharma Inc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.acastipharma.com
Headquarters
Jersey City, New Jersey, USA
Founded
-
Acasti Pharma Inc is listed in the Pharmaceutical Preparations sector of the TSX Venture Exchange with ticker ACST. The last closing price for Acasti Pharma was $0.58. Over the last year, Acasti Pharma shares have traded in a share price range of $ 0.58 to $ 0.58.

Acasti Pharma currently has 9,399,000 shares outstanding. The market capitalization of Acasti Pharma is $5.45 million. Acasti Pharma has a price to earnings ratio (PE ratio) of -2.46.

Ask ADVFN Intelligence (AI)

ACST Latest News

More News

Acasti Pharma Reports Third Quarter 2023 Operational Results

Company to Host Conference Call Today at 1:00pm ET LAVAL, Québec, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a...

February 14 2023
GlobeNewswire Inc.

Acasti Receives Extension to Regain Compliance with NASDAQ Minimum Bid Price Rule

LAVAL, Québec, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

January 25 2023
GlobeNewswire Inc.

Acasti Pharma to Present at Lytham Partners Investor Select Conference on January 31

LAVAL, Québec, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

January 24 2023
GlobeNewswire Inc.

Acasti Pharma to Present at Sidoti Virtual Investor Conference on January 18

LAVAL, Québec, Jan. 13, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

January 13 2023
GlobeNewswire Inc.

Acasti to Host Conference Call on Tuesday, January 10, 2023 to Discuss Results from Recent Phase 1 PK Studies for GTX-101 and GTX-102 That Met All Outcome Measures

LAVAL, Québec, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

January 05 2023
GlobeNewswire Inc.

Acasti Announces Preliminary Topline Results Met All Outcome Measures in the Pharmacokinetic Bridging Study for GTX-102, the Company’s Drug Candidate for the Treatment of Ataxia Telangiectasia

LAVAL, Québec, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

December 28 2022
GlobeNewswire Inc.

Acasti Pharma Announces Preliminary Topline Results Met All Primary Outcome Measures in the Single Dose Pharmacokinetic Study for GTX-101, the Company’s Drug Candidate for the Treatment of Postherpetic Neuralgia (PHN)

LAVAL, Québec, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

December 22 2022
GlobeNewswire Inc.

Acasti Pharma Reports Second Quarter 2023 Operational Results

Company to Host Conference Call Today at 1:00pm ET LAVAL, Québec, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a...

November 14 2022
GlobeNewswire Inc.

Acasti Pharma to Present at Q4 Investor Summit

LAVAL, Québec, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

November 09 2022
GlobeNewswire Inc.

Acasti Pharma to Report Second Quarter 2023 Financial Results on Monday, November 14, 2022

LAVAL, Quebec, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three clinical...

November 07 2022
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.580.580.5800CS
4000.580.580.5800CS
12000.580.580.5800CS
26000.580.580.5800CS
52000.580.580.5800CS
156-0.93-61.58940397351.511.660.4713711.03488033CS
260-0.37-38.94736842110.953.680.22935570.7630343CS

ACST - Frequently Asked Questions (FAQ)

What is the current Acasti Pharma share price?
The current share price of Acasti Pharma is $ 0.58
How many Acasti Pharma shares are in issue?
Acasti Pharma has 9,399,000 shares in issue
What is the market cap of Acasti Pharma?
The market capitalisation of Acasti Pharma is CAD 5.45M
What is the 1 year trading range for Acasti Pharma share price?
Acasti Pharma has traded in the range of $ 0.58 to $ 0.58 during the past year
What is the PE ratio of Acasti Pharma?
The price to earnings ratio of Acasti Pharma is -2.46
What is the reporting currency for Acasti Pharma?
Acasti Pharma reports financial results in USD
What is the latest annual profit for Acasti Pharma?
The latest annual profit of Acasti Pharma is USD -12.85M
What is the registered address of Acasti Pharma?
The registered address for Acasti Pharma is 103 CARNEGIE CENTER, SUITE 300 PRINCETON, JERSEY CITY, NEW JERSEY, 08540
What is the Acasti Pharma website address?
The website address for Acasti Pharma is www.acastipharma.com
Which industry sector does Acasti Pharma operate in?
Acasti Pharma operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ATR.PAster Acquisition Corp
$ 0.045
(350.00%)
11k
AGH.HCanadian Silver Hunter Inc
$ 0.035
(133.33%)
11k
RAC.PRiverwalk Acquisition Corp
$ 0.03
(100.00%)
10k
ODX.HOdyssey Resources Limited
$ 0.05
(100.00%)
120k
KLXCarbon Done Right Developments Inc
$ 0.02
(100.00%)
942.5k
ALTAlturas Minerals Corp
$ 0.005
(-50.00%)
41k
TVC.HThree Valley Copper Corp
$ 0.005
(-50.00%)
57.9k
DGTL.HDGTL Holdings Inc
$ 0.03
(-40.00%)
6k
VPIVitality Products Inc
$ 0.015
(-40.00%)
12k
NXSNexus Gold Corp
$ 0.01
(-33.33%)
4.9k
ATXAtex Resources Inc
$ 2.00
(8.11%)
6.57M
WFLDWellfield Technologies Inc
$ 0.02
(-20.00%)
3.66M
NDANeptune Digital Assets Corp
$ 2.79
(28.57%)
3.32M
QNCQuantum Emotion Corp
$ 0.65
(-14.47%)
2.85M
TUKTuktu Resources Ltd
$ 0.145
(7.41%)
2.41M

Discussion

View Full Feed
gdl gdl 5 minutes ago
Middle of a despot's total control of this country and you only see profits. Like a pandemic declared and everyone ignored it. NO ONE can ever argue the facts on Trump, can they. they might approve or think it benefits them BUT not that he is a MONSTER.

Trump has 2 years to fix the
SPY
rbtree rbtree 11 minutes ago
Ummm, hate to break it to ya, but that is old news from over a year ago...

Meanwhile, this pig bounces between .000001 and .0001... does it even have a bid anymore?
KEGS
jeunke22 jeunke22 14 minutes ago
Just to prove that we need more low latency, bandwidth and speed …. This is the answer to a simple question:
“ Sorry, DeepSeek search service is busy. Please disable search or try again later.”
LWLG
gdl gdl 18 minutes ago
Not only has all 3 branches of government greedily abandoned their pledge they also have lost their souls. I warned, no insisted this was happening. it spells the end of our Republic and end of the stock market. no not for a year or 5 but for decades. The godlike Trump flexes and extends his muscl
RuudSaltis RuudSaltis 23 minutes ago
That’s why he needs only 6 months….! He has a razer sharp plan. It’s amazing how he communicates also one on one with shareholders…
LWLG
wagner wagner 23 minutes ago
I would bet no smart money in before the Exim in on stage... 
NB
Truenorth2016 Truenorth2016 27 minutes ago
Just a Reminder to you and anyone lurking, we just saw the Quantum Computing Healthcare stock RG*ti run from .66 cents to $21.00 in a few months. What people need to understand is GCAN already told us they are being approach by companies for a Quantum Computing /AI merger "BUT" I the CEO never told
GCAN
ramfan60 ramfan60 30 minutes ago
What's wrong with the wingnut? You must be happy with the wonderful job our FDA and NIH have done regulating our food and nutrition over the past 50 years. RFK is passionate about Making America Healthy Again......I'm all for it and he can't get confirmed fast enough as far as I'm concerned.
AMRN
ron_66271 ron_66271 36 minutes ago
Thank for Supporting My Argument.

JPM didn’t have the money to cover Lehman’s ‘Market to Market’ of $17 Billion on September 14th.

Need more?

“BlackRock?”
Why…


All Classes are in the Money.



Ron
JPM
Zorax Zorax 37 minutes ago
He's going to sell them shitface bibles.
Doc logic Doc logic 38 minutes ago
exwannabe,

Simply put: Crossover to an active substance instead of placebo required that the active substance being utilized in the crossover be measured against a comparable group being treated with anything other than a known active substance. Comparators had to be changed when SO
NWBO
ron_66271 ron_66271 47 minutes ago
CTS are in the Same Camp as Preferred Shares.

Securitized by Derivative Contracts.

You didn’t understand the Derivative Market Meltdown of 2008.

Lehman’s wasn’t the problem.
JPM was.



Ron
JPM
littlejohn littlejohn 52 minutes ago
Traders who played other big names for

Wednesday could start back in

here on the cheapies...

META and MSFT make a lot of money...

And can spend on Ai - R and D...

Seems a good money flow watch...

so we watch..
MSFT
hbhmb hbhmb 53 minutes ago
You are right. To much going on behind the scenes. Also the volume ( or lack of such) is causing the swings allowing flippers to flip
Hopefully the next quarters financials will continue improving and with the new web site am hoping we start moving nicely.
AIAD
Wrangler1 Wrangler1 56 minutes ago
Wonder why he's deleting posts? Probably  because he realizes he is wrong once again. What an absolute joke. 
WDLF
Golfnut3 Golfnut3 56 minutes ago
Thanks for the input...
ALYI
littlejohn littlejohn 1 hour ago
Fine idea, put sellers on 28 turned bullish

on Wednesday with big volume...

https://www.barchart.com/stocks/quotes/SMCI/options?expiration=2025-01-31-w&moneyness=20

those are willing share buyers at 28

if they get exercised with a close on
SMCI
trader53 trader53 1 hour ago
DPLS 0.0004 - Short Squeeze Soon!


I'll Alert you of stocks to Buy,
before the Run happens !

https://investorshub.advfn.com/uicon/155361.png?cb=636360310707230000
________________________________________________


https://
DPLS MFI
Plato_ Plato_ 1 hour ago
https://investorshub.advfn.com/uimage/uploads/2025/1/30/jkzcuLinkedIn.png
About us

VeeMost Technologies Inc. is your trusted partner in delivering innovative, customer-focused IT solutions designed to empower your business. As a minority-owned technology provider,
GDVM
blackcat blackcat 1 hour ago
Pretty horrifying situation. Not something you'd think could happen- although it was night and it is a busy airport.
dinogreeves dinogreeves 1 hour ago
SMCI after the report it will get to the right valuation with time.
SMCI
dinogreeves dinogreeves 1 hour ago
DeepSeek is fake.
SMCI
toogoodfella toogoodfella 1 hour ago
IF YOU THINK THE BALANCE SHEET IS WRONG, BE A WHISLE BLOWER
YOULL BECOME VERY FAMOUS

LEHNQ
trader53 trader53 1 hour ago
DPLS 0.0004 - Point of Maximum Financial Opportunity


I'll Alert you of stocks to Buy,
before the Run happens !

https://investorshub.advfn.com/uicon/155361.png?cb=636360310707230000
________________________________________________
DPLS MFI

Your Recent History

TSXV
ACST
Acasti Pharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads